Innovating Works

FHR

TIMER: TargetIng novel MEchanisms of Resolution in inflammation FONDAZIONE HUMANITAS PER LA RICERCA tramitó un FP7: Resolution of inflammation is a key determinant of pathology, and an active process which involves diverse pathways and molecules. The gener...
Financiado
TOLERAGE: Normalisation of immune reactivity in old age from basic mechanisms to clinical application FONDAZIONE HUMANITAS PER LA RICERCA participó en un FP7: When restoration of the immune response in older age is the target of basic and clinical research, boosting innate and adaptive immunity, e....
Financiado
BTCURE: BeTheCuRE FONDAZIONE HUMANITAS PER LA RICERCA participó en un FP7: BTCure is based on the recognition that RA is a heterogeneous disease where a major subset involves adaptive immunity, and that animal model...
Financiado
SYBILLA: Systems Biology of T cell Activation in Health and Disease FONDAZIONE HUMANITAS PER LA RICERCA participó en un FP7: T-cell activation, whether induced by pathogens or auto-antigens, is a complex process relying on multiple layers of tightly controlled intr...
Financiado
MERLIN: MEsenchymal stem cells to Reduce Liver INflammation FONDAZIONE HUMANITAS PER LA RICERCA participó en un FP7: Prevalence of liver disease is c6% (29 million people) in the EU with mortality rates from chronic liver diseases estimated at 14.3 per 100....
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.